Navigation Links
LifeNet Health and Salvin Dental Specialties Announce Partnership
Date:6/17/2010

VIRGINIA BEACH, Va., June 17 /PRNewswire/ -- Salvin Dental Specialties, Inc. and LifeNet Health are pleased to announce they have signed an exclusive agreement  to advance LifeNet Health's OraGraft™ allograft products in the dental market.

The two companies have been in partnership since 1995. The new agreement builds on the existing relationship between these two companies, which provides LifeNet Health with Salvin Dental's strong, nationally recognized marketing and sales resources, while LifeNet Health's industry-leading reputation and quality allograft products offer a great bone grafting solution for Salvin Dental customers. LifeNet Health will continue to provide educational and research support to the dental community as well as continual support to its current clients through direct distribution.

Salvin Dental was founded in 1981 and is a global leader in the dental implant industry for bone grafting, instrumentation, and equipment. LifeNet Health, founded in 1982, is the country's largest, independent, non-profit, full-service tissue bank.

Under the agreement, Salvin Dental will act as the exclusive U.S. representative for the promotion of OraGraft™ allograft tissue products in the dental industry along with LifeNet Health. Salvin Dental will increase awareness in the dental industry about the availability of allograft products, which may be particularly beneficial for implant bone grafting and sinus lift procedures.

LifeNet Health is responsible for allograft procurement, processing, and distribution. The company utilizes the latest research and processing techniques to assure the highest quality donor screening and follows strict standards regarding donor qualification, tissue processing, and quality system review. Since introducing Allowash® technology in 1995, LifeNet Health has distributed more than 2.4 million allograft products without incidence of disease transmission.  

Bob Salvin, Founder and CEO for Salvin Dental, said, "Because of LifeNet Health's world-class reputation for its stringent quality processes and Salvin Dental's understanding of the bone grafting needs of the dental industry, this partnership benefits the customers we serve."

Rony Thomas, LifeNet Health's President and CEO, stated, "We are committed to working with Salvin Dental to provide LifeNet Health's OraGraft™ allograft to the patients who need them, and we are proud to be a part of the comprehensive Salvin Dental product offering."

Salvin Dental Specialties, Inc. is dedicated to providing innovative products and exceeding customers' expectations for quality, value, and service every time they call. For additional information about Salvin Dental Specialties, Inc., visit www.salvin.com.

LifeNet Health helps save lives and restore health for thousands of patients each year. LifeNet Health is the world's most trusted provider of transplant solutions, from organ procurement to new innovations in bio-implant technologies and cellular therapies—a leader in the field of regenerative medicine while always honoring the donors and healthcare professionals that allow the healing process.  For additional information about LifeNet Health, visit www.lifenethealth.org.


'/>"/>
SOURCE LifeNet Health
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. LifeNet Health Announces First Bio-Implant with New Preservation Technology
2. New Publications Highlight LifeNet Healths Life Saving Work in Neurosurgery
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
5. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. Tone Deafness Explained, from the Harvard Health Letter
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
10. ViroPharma to Present at Three Upcoming Healthcare Conferences
11. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... CHAPEL HILL, N.C. , June 24, 2016 ... in healthcare decisions and regulators/payers have placed more ... this new environment, patient support programs in the ... support for patients, medications. Consequently, pharmaceutical companies are ... to ensure they are providing products and services ...
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
Breaking Medicine News(10 mins):